New hope for advanced cancer: AWT020 trial launches
Disease control
Recruiting now
This early-stage trial tests a new drug, AWT020, in about 60 adults with advanced solid tumors or lymphoma that has not responded to standard treatments. The main goals are to check the drug's safety at different doses and to see how the body processes it. This study is a first s…
Phase: PHASE1 • Sponsor: Anwita Biosciences • Aim: Disease control
Last updated May 15, 2026 11:57 UTC